# Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent

> **NCT01512563** · NA · COMPLETED · sponsor: **Taewoong Medical Co., Ltd.** · enrollment: 106 (actual)

## Conditions studied

- Biliary Stricture
- Malignant Neoplasms

## Interventions

- **DEVICE:** Biliary stent

## Key facts

- **NCT ID:** NCT01512563
- **Lead sponsor:** Taewoong Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01512563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01512563, "Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01512563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*